Zhuhai Rundu Pharmaceutical Co Ltd Class A Strategic Asset Allocation Index
Zhuhai Rundu Pharmaceutical Co Ltd Class A strategic asset allocation index. Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a Strategic Asset Allocation Index of 100.9% as of September 2023. Strategic assets (PP&E of CN¥1.19 Billion plus long-term investments of CN¥-) total CN¥1.19 Billion, measured against net assets of CN¥1.18 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Zhuhai Rundu Pharmaceutical Co Ltd Class's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Zhuhai Rundu Pharmaceutical Co Ltd Class A (2016–2022)
Strategic asset allocation index of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2016 to 2022. This chart shows how Zhuhai Rundu Pharmaceutical Co Ltd Class A's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of September 2023, the index stands at 100.9%, representing strategic assets of CN¥1.19 Billion against net assets of CN¥1.18 Billion CNY. Check Zhuhai Rundu Pharmaceutical Co Ltd Class (002923) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Zhuhai Rundu Pharmaceutical Co Ltd Class A Strategic Asset Allocation Index by Year (2016–2022)
Zhuhai Rundu Pharmaceutical Co Ltd Class A strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002923 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 102.3% | CN¥1.22 Billion | CN¥1.22 Billion | CN¥- | CN¥1.20 Billion | ▲ +14.9 pp |
| 2021 | 87.4% | CN¥972.57 Million | CN¥972.57 Million | CN¥- | CN¥1.11 Billion | ▲ +31.4 pp |
| 2020 | 56.1% | CN¥581.99 Million | CN¥581.99 Million | CN¥- | CN¥1.04 Billion | ▲ +9.2 pp |
| 2019 | 46.8% | CN¥440.44 Million | CN¥440.44 Million | CN¥- | CN¥940.29 Million | ▲ +11.3 pp |
| 2018 | 35.5% | CN¥309.38 Million | CN¥309.38 Million | CN¥- | CN¥871.29 Million | ▼ -15.3 pp |
| 2017 | 50.8% | CN¥248.42 Million | CN¥248.42 Million | CN¥- | CN¥488.84 Million | ▼ -12.6 pp |
| 2016 | 63.5% | CN¥252.67 Million | CN¥252.67 Million | CN¥- | CN¥398.19 Million | — |